Replies to post #335891 on Anavex Life Sciences Corp (AVXL)

[xodcode]

That TGD is included in the upcoming Lausanne Workshop (Nov 15-18) is a big deal as TGD will be rubbing elbows with elite influencers and decision makers. (i.e. the Organisation for Economic Co-Operation and Development (OECD) and supported by The Global CEO Initiative on Alzheimer’s Disease (CEOi), Alzheimer’s Disease International (ADI) and World Economic Forum (WEF).) and decision makers.

"Over the past seven years, the Workshop has become a highly-curated platform for global Alzheimer’s stakeholders to identify challenges, set solution paths, measure progress and hold each other accountable to act."

"Christopher U. Missling, PhD, will join the panel, “Exploring the Promise of Novel Therapeutic Approaches,” at the Lausanne VIII Workshop on Wednesday, November 17th at 10:00 a.m. EST to 11:00 a.m. EST."

This forum provides TGD a forum to demonstrate AVXL's "measurable progress" in the meeting the Lausanne VIII objective of stopping dementia by 2025

[HMB2010]

"People like Dr.M. are the existing systems worst nightmare ... IMO.

Nothing short of undeniably brilliant AVXL results will move the needle when corruption like this controls the system. IMO. "


Fortunately Dr M is all too knowing this as well.

Allowing evidence to build (for protein mis-folding and against plaque theory) by unrelated entity studies is the bonus during our delay.